| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Min Yan | |
| Wei Xu | |||
| Wen-Tao Liu | |||
| Zheng-Gang Zhu | |||
| Jian-Peng Gao | |||
| P2860 | cites work | ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal | Q21246014 |
| The spatial distribution of LGR5+ cells correlates with gastric cancer progression | Q21560986 | ||
| The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial | Q24629295 | ||
| Mature chief cells are cryptic progenitors for metaplasia in the stomach | Q24631089 | ||
| Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened | Q24682703 | ||
| Clonal evolution models of tumor heterogeneity | Q26863470 | ||
| Gastric cancer stem cells: a novel therapeutic target | Q27002840 | ||
| Cancer stem cells--the current status of an old concept: literature review and clinical approaches | Q27025165 | ||
| Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
| Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations | Q28080701 | ||
| Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell | Q28188430 | ||
| CD44 in cancer | Q28217782 | ||
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| Identification of selective inhibitors of cancer stem cells by high-throughput screening | Q28255115 | ||
| A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapy | Q28475529 | ||
| Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells | Q28476445 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro | Q29616198 | ||
| Influence of tumour micro-environment heterogeneity on therapeutic response | Q29617534 | ||
| Heterogeneity in cancer: cancer stem cells versus clonal evolution | Q29622839 | ||
| Identifying and targeting cancer stem cells in the treatment of gastric cancer | Q30238811 | ||
| Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells | Q33317848 | ||
| Tumor initiating potential of side population cells in human gastric cancer. | Q33429081 | ||
| Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling | Q39071833 | ||
| Heterogeneity of tumor cells in terms of cancer-initiating cells | Q39132578 | ||
| Intra-tumor heterogeneity from a cancer stem cell perspective. | Q39139446 | ||
| Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy | Q39188768 | ||
| Induction of tumor stem cell differentiation--novel strategy to overcome therapy resistance in gastric cancer | Q39193995 | ||
| The self-renewal signaling pathways utilized by gastric cancer stem cells | Q39221222 | ||
| Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties | Q39228334 | ||
| Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. | Q39376769 | ||
| Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. | Q39403553 | ||
| Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line | Q39474693 | ||
| Identification of CD44+CD24+ gastric cancer stem cells | Q39481277 | ||
| Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer | Q39690008 | ||
| Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells | Q39793946 | ||
| mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells | Q39802014 | ||
| Identification of gastric cancer stem cells using the cell surface marker CD44. | Q39856772 | ||
| Objective analysis of cancer stem cell marker expression using immunohistochemistry | Q40425588 | ||
| Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma | Q40543081 | ||
| ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population | Q41273119 | ||
| Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells | Q41417680 | ||
| Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma. | Q42465206 | ||
| Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). | Q42608504 | ||
| Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy | Q42722265 | ||
| Helicobacter pylori: Bone-marrow-derived cells could cause gastric preneoplasia in chronic Helicobacter pylori infection | Q43533331 | ||
| Rilotumumab exposure-response relationship in patients with advanced or metastatic gastric cancer | Q46084784 | ||
| Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205). | Q46567504 | ||
| LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence | Q38769502 | ||
| Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer | Q38789123 | ||
| CD90 a potential cancer stem cell marker and a therapeutic target | Q38803617 | ||
| Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. | Q38807957 | ||
| Lgr5-Positive Cells are Cancer-Stem-Cell-Like Cells in Gastric Cancer | Q38843205 | ||
| miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells | Q38950242 | ||
| Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation | Q39045264 | ||
| Notch as a Driver of Gastric Epithelial Cell Proliferation | Q33600442 | ||
| Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations | Q33608197 | ||
| Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment | Q33695152 | ||
| Isolation of cancer progenitor cells from cancer stem cells in gastric cancer | Q33702282 | ||
| Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells | Q33711746 | ||
| Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer | Q33843343 | ||
| CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance | Q34055274 | ||
| Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? | Q34103451 | ||
| Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity | Q34135305 | ||
| Tumor-initiating cells are rare in many human tumors | Q34156000 | ||
| Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. | Q34164197 | ||
| Not all side population cells contain cancer stem-like cells in human gastric cancer cell lines | Q34373503 | ||
| Evolution of the cancer stem cell model | Q34408981 | ||
| Cancer stem cell plasticity and tumor hierarchy | Q34459650 | ||
| Regulation of NANOG in cancer cells | Q34478004 | ||
| Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. | Q34629266 | ||
| Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis | Q34688350 | ||
| Generation of pluripotent stem cells from adult mouse liver and stomach cells | Q34750323 | ||
| Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma | Q34948623 | ||
| Bone marrow-derived cells may not be the original cells for carcinogen-induced mouse gastrointestinal carcinomas | Q35048576 | ||
| 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells | Q35069199 | ||
| Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab | Q35109585 | ||
| Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. | Q35112119 | ||
| Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. | Q35120899 | ||
| Breast cancer stem cells, cytokine networks, and the tumor microenvironment | Q35571904 | ||
| ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells | Q35581773 | ||
| Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26. | Q35742283 | ||
| Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients | Q35958829 | ||
| The evolving concept of cancer and metastasis stem cells | Q36145729 | ||
| Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases | Q47127455 | ||
| A clinical trial protocol paper discussing the BRIGHTER study | Q47753559 | ||
| Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. | Q50508280 | ||
| Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. | Q51928042 | ||
| Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. | Q53067336 | ||
| Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. | Q53341224 | ||
| Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. | Q53384216 | ||
| Intratumoral heterogeneity in gastric cancer: a new challenge to face. | Q53385547 | ||
| Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. | Q54360289 | ||
| Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer | Q73670201 | ||
| Gastric cancer originating from bone marrow-derived cells | Q81067451 | ||
| Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions | Q82782824 | ||
| Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research | Q83745627 | ||
| Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer | Q85090123 | ||
| Cancer stem cells: the challenges ahead | Q86523719 | ||
| Expanding the Lauren classification: a new gastric cancer subtype? | Q87156198 | ||
| CD44v8-10 is a cancer-specific marker for gastric cancer stem cells | Q87423294 | ||
| Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics | Q36214625 | ||
| Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice | Q36336785 | ||
| Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche. | Q36386294 | ||
| CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. | Q36483451 | ||
| Expression of stem cell markers nanog and PSCA in gastric cancer and its significance | Q36502900 | ||
| Prospective identification of a multilineage progenitor in murine stomach epithelium | Q36579048 | ||
| Mechanisms of chemoresistance in cancer stem cells | Q36591484 | ||
| Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions | Q36636235 | ||
| Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer | Q36732896 | ||
| Targeted therapy for cancer stem cells: the patched pathway and ABC transporters | Q36745386 | ||
| Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer | Q36962804 | ||
| Gastric cancer stem cells | Q37186444 | ||
| Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis | Q37338336 | ||
| Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets | Q37583804 | ||
| Epigenetics in cancer stem cells | Q37618640 | ||
| Potential for therapeutic targeting of tumor stem cells | Q37622478 | ||
| Deletion of IQGAP1 promotes Helicobacter pylori-induced gastric dysplasia in mice and acquisition of cancer stem cell properties in vitro | Q37684660 | ||
| The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms | Q37685452 | ||
| HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway | Q37706009 | ||
| Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation | Q37715796 | ||
| Gastric carcinogenesis and the cancer stem cell hypothesis | Q37725726 | ||
| Hypoxia and hypoxia inducible factors in cancer stem cell maintenance | Q37768064 | ||
| Gastric cancer stem cells: therapeutic targets. | Q38096903 | ||
| CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches | Q38100108 | ||
| The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment | Q38178133 | ||
| Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment | Q38212216 | ||
| Development of gastric cancer and its prevention | Q38224742 | ||
| Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial | Q38383859 | ||
| Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil | Q38490073 | ||
| Mechanisms of Resistance to Chemotherapy in Gastric Cancer. | Q38559156 | ||
| Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications | Q38723978 | ||
| miR‑483‑5p promotes growth, invasion and self‑renewal of gastric cancer stem cells by Wnt/β‑catenin signaling | Q38752593 | ||
| Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future | Q38758819 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | carcinogenesis | Q1637543 |
| neoplastic stem cells | Q1638475 | ||
| tumor microenvironment | Q1786433 | ||
| stomach neoplasm | Q4335552 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2567-2581 | |
| P577 | publication date | 2018-06-01 | |
| 2018-06-28 | |||
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell | |
| P478 | volume | 24 |
| Q92343509 | Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells |
| Q89928216 | Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data |
| Q64990427 | Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. |
| Q64951606 | The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. |
| Q93012980 | VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma |
Search more.